Table: Towa Pharmaceutical -9-MTH group results

TOWA PHARMACEUTICAL

13/02/2017 06:00

Feb 13 (Reuters)-  
             Towa Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2016        Dec 31, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               63.70               61.23            88.40     
                   (+4.0 pct)          (+15.4 pct)      (+7.7 pct)   
  Operating            5.51                8.92             7.20     
                   (-38.3 pct)         (+3.6 pct)       (-35.3 pct)  
  Recurring            6.50                8.93             5.10     
                   (-27.2 pct)         (-28.6 pct)      (-49.8 pct)  
  Net                  4.80                6.31             3.60     
                   (-23.8 pct)         (-29.2 pct)      (-53.2 pct)  
  EPS              292.92 yen          378.34 yen       219.47 yen   
  EPS Diluted      270.80 yen          359.20 yen                    
  Ann Div                               95.00 yen        95.00 yen   
  -Q2 div           47.50 yen           47.50 yen                    
  -Q4 div                               47.50 yen        47.50 yen   
   
  NOTE - Towa Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T 
  ((Tokyo Headline News Desk +813 6441 1812))